- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30441
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Hepatitis B genotype C linked to increased hepatoma risk
Last Updated: 2013-01-25 17:25:09 -0400 (Reuters Health)
By Will Boggs, MD
NEW YORK (Reuters Health) - Of all the major hepatitis B virus (HBV) genotypes, genotype C carries the highest risk for hepatocellular carcinoma (HCC), Chinese researchers say.
"These findings are useful when we decide the need of antiviral therapy and intensity of HCC surveillance," Dr. Grace L.-H. Wong from The Chinese University of Hong Kong told Reuters Health. "The treatment threshold for patients infected by genotype C HBV should be probably lower than (for) those infected by other genotypes. Also patients infected by genotype C HBV should have more frequent HCC screening tests."
As reported online January 10 in Alimentary Pharmacology and Therapeutics, Dr. Wong and colleagues used a meta-analysis of 43 studies involving 14,545 patients to investigate the relative risk of HCC among the four major HBV genotypes (A, B, C, and D).
In the 33 studies with data on patients with genotypes B and C, HCC occurred about twice as often with genotype C HBV as with genotype B HBV (25% vs 13%; p<0.001).
HCC rates did not differ significantly between genotypes A and D (14% vs 11%; p=0.71), in the 12 studies that compared them.
Ten studies included patients with genotypes A and/or D and genotype C. In these, HCC rates were significantly higher with genotype C (30% vs 7%; p<0.001).
In eight studies, there was no significant difference in HCC risk between subgenotypes Ce and Cs (41% vs 28%; p =0.54).
|
|